Yu 2020c.

Study characteristics
Patient Sampling	The included patients were subdivided in : ‐ chronic hepatitis B patients (CHB group) ‐ HBV‐related liver cirrhosis patients(liver cirrhosis group) ‐ HBV‐related HCC patients (HCC group) Age range and % males not reported
Patient characteristics and setting
Index tests	Serum AFP measurement: no specification. Predefined cut‐off value 20 ng/mL
Target condition and reference standard(s)	HCC diagnosed by two experienced pathologists. If no tissue available, diagnosis must be supported by two image reports (ultrasound B, CT, or MRI). Cirrhosis diagnosed by two experienced pathologists. If no tissue available, diagnosis must be supported by two image reports (ultrasound B, CT, or MRI). CHB no definition
Flow and timing	No information on interval between index test and reference standard
Comparative
Notes	"The authors declare no potential conflict of interest."
Methodological quality
Item	Authors' judgement	Risk of bias	Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled?	No
Was a case‐control design avoided?	No
Did the study avoid inappropriate exclusions?	No
Could the selection of patients have introduced bias?		High risk
Are there concerns that the included patients and setting do not match the review question?			High
DOMAIN 2: Index Test (AFP)
Were the index test results interpreted without knowledge of the results of the reference standard?	Yes
If a threshold was used, was it pre‐specified?	Yes
Could the conduct or interpretation of the index test have introduced bias?		Low risk
Are there concerns that the index test, its conduct, or interpretation differ from the review question?			Low concern
DOMAIN 2: Index Test (US+AFP)
Were the index test results interpreted without knowledge of the results of the reference standard?
If a threshold was used, was it pre‐specified?
Could the conduct or interpretation of the index test have introduced bias?
Are there concerns that the index test, its conduct, or interpretation differ from the review question?
DOMAIN 2: Index Test (US)
Were the index test results interpreted without knowledge of the results of the reference standard?
If a threshold was used, was it pre‐specified?
Could the conduct or interpretation of the index test have introduced bias?
Are there concerns that the index test, its conduct, or interpretation differ from the review question?
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition?	No
Were the reference standard results interpreted without knowledge of the results of the index tests?	Yes
Could the reference standard, its conduct, or its interpretation have introduced bias?		High risk
Are there concerns that the target condition as defined by the reference standard does not match the question?			Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard?	Unclear
Did all patients receive the same reference standard?	No
Were all patients included in the analysis?	Yes
Could the patient flow have introduced bias?		High risk